Literature DB >> 16773716

Gene expression profiling defined pathways correlated with fibroblast cell proliferation induced by Opisthorchis viverrini excretory/secretory product.

Chanitra Thuwajit1, Peti Thuwajit, Kazuhiko Uchida, Daoyot Daorueang, Sasithorn Kaewkes, Sopit Wongkham, Masanao Miwa.   

Abstract

AIM: To investigate the mechanism of fibroblast cell proliferation stimulated by the Opisthorchis viverrini excretory/secretory (ES) product.
METHODS: NIH-3T3, mouse fibroblast cells were treated with O. viverrini ES product by non-contact co-cultured with the adult parasites. Total RNA from NIH-3T3 treated and untreated with O. viverrini was extracted, reverse transcribed and hybridized with the mouse 15K complementary DNA (cDNA) array. The result was analyzed by ArrayVision version 5 and GeneSpring version 5 softwares. After normalization, the ratios of gene expression of parasite treated to untreated NIH-3T3 cells of 2-and more-fold upregulated was defined as the differentially expressed genes. The expression levels of the signal transduction genes were validated by semi-quantitative SYBR-based real-time RT-PCR.
RESULTS: Among a total of 15,000 genes/ESTs, 239 genes with established cell proliferation-related function were 2 fold-and more-up-regulated by O. viverrini ES product compared to those in cells without exposure to the parasitic product. These genes were classified into groups including energy and metabolism, signal transduction, protein synthesis and translation, matrix and structural protein, transcription control, cell cycle and DNA replication. Moreover, the expressions of serine-threonine kinase receptor, receptor tyrosine kinase and collagen production-related genes were up-regulated by O. viverrini ES product. The expression level of signal transduction genes; pkC, pdgfr alpha, jak 1, eps 8, tgf beta 1i4, strap and h ras measured by real-time RT-PCR confirmed their expression levels to those obtained from cDNA array. However, only the up-regulated expression of pkC, eps 8 and tgfbeta 1i4 which are the downstream signaling molecules of either epidermal growth factor (EGF) or transforming growth factor-beta (TGF-beta) showed statistical significance (P < 0.05).
CONCLUSION: O. viverrini ES product stimulates the significant changes of gene expression in several functional categories and these mainly include transcripts related to cell proliferation. The TGF-beta and EGF signal transduction pathways are indicated as the possible pathways of O. viverrini-driven cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16773716      PMCID: PMC4087575          DOI: 10.3748/wjg.v12.i22.3585

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

Review 1.  Regulation of cell cycle re-entry by growth, survival and stress signalling pathways.

Authors:  S J Cook; K Balmanno; A Garner; T Millar; C Taverner; D Todd
Journal:  Biochem Soc Trans       Date:  2000-02       Impact factor: 5.407

2.  Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR.

Authors:  T D Schmittgen; B A Zakrajsek
Journal:  J Biochem Biophys Methods       Date:  2000-11-20

3.  Expression of TGF-beta stimulated clone-22 (TSC-22) in mouse development and TGF-beta signalling.

Authors:  H A Kester; T M Ward-van Oostwaard; M J Goumans; M A van Rooijen; P T van Der Saag; B van Der Burg; C L Mummery
Journal:  Dev Dyn       Date:  2000-08       Impact factor: 3.780

4.  Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.

Authors:  S D Taylor-Robinson; M B Toledano; S Arora; T J Keegan; S Hargreaves; A Beck; S A Khan; P Elliott; H C Thomas
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

5.  The transcriptional program in the response of human fibroblasts to serum.

Authors:  V R Iyer; M B Eisen; D T Ross; G Schuler; T Moore; J C Lee; J M Trent; L M Staudt; J Hudson; M S Boguski; D Lashkari; D Shalon; D Botstein; P O Brown
Journal:  Science       Date:  1999-01-01       Impact factor: 47.728

Review 6.  Extracellular matrix and integrin signalling: the shape of things to come.

Authors:  N J Boudreau; P L Jones
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

7.  STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling.

Authors:  P K Datta; H L Moses
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 8.  Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?

Authors:  Patrick Micke; Arne Ostman
Journal:  Lung Cancer       Date:  2004-08       Impact factor: 5.705

Review 9.  Liver fibrosis.

Authors:  Ramón Bataller; David A Brenner
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

10.  Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Authors:  A F Olumi; G D Grossfeld; S W Hayward; P R Carroll; T D Tlsty; G R Cunha
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

View more
  18 in total

1.  Apoptosis-related gene expression in hamster opisthorchiasis post praziquantel treatment.

Authors:  T Boonmars; P Srirach; B Kaewsamut; T Srisawangwong; S Pinlaor; P Pinlaor; P Yongvanit; P Sithithaworn
Journal:  Parasitol Res       Date:  2007-12-06       Impact factor: 2.289

2.  Candidate genes involving in tumorigenesis of cholangiocarcinoma induced by Opisthorchis viverrini infection.

Authors:  Zhiliang Wu; Thidarut Boonmars; Sirintip Boonjaraspinyo; Isao Nagano; Somchai Pinlaor; Anucha Puapairoj; Puangrat Yongvanit; Yuzo Takahashi
Journal:  Parasitol Res       Date:  2011-03-05       Impact factor: 2.289

Review 3.  Infection with the carcinogenic human liver fluke, Opisthorchis viverrini.

Authors:  Michael J Smout; Banchob Sripa; Thewarach Laha; Jason Mulvenna; Robin B Gasser; Neil D Young; Jeffrey M Bethony; Paul J Brindley; Alex Loukas
Journal:  Mol Biosyst       Date:  2011-02-11

Review 4.  Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand.

Authors:  Masanao Miwa; Satoshi Honjo; Gyokukou You; Masakazu Tanaka; Kazuhiko Uchida; Petcharin Srivatanakul; Thiravud Khuhaprema; Watcharin Loilome; Anchalee Techasen; Chaisiri Wongkham; Temduang Limpaiboon; Puangrat Yongvanit; Sopit Wongkham
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 5.  Cholangiocarcinoma: new insights into disease pathogenesis and biology.

Authors:  Chiara Braconi; Tushar Patel
Journal:  Infect Dis Clin North Am       Date:  2010-12       Impact factor: 5.982

6.  Indirect effect of a turmeric diet: enhanced bile duct proliferation in Syrian hamsters with a combination of partial obstruction by Opisthorchis viverrini infection and inflammation by N-nitrosodimethylamine administration.

Authors:  Sirintip Boonjaraspinyo; Thidarut Boonmars; Chantana Aromdee; Anucha Puapairoj; Zhiliang Wu
Journal:  Parasitol Res       Date:  2010-09-07       Impact factor: 2.289

7.  Alterations of gene expression of RB pathway in Opisthorchis viverrini infection-induced cholangiocarcinoma.

Authors:  Thidarut Boonmars; Zhiliang Wu; Sirintip Boonjaruspinyo; Somchai Pinlaor; Isao Nagano; Yuzo Takahashi; Butsara Kaewsamut; Puangrat Yongvanit
Journal:  Parasitol Res       Date:  2009-07-07       Impact factor: 2.289

Review 8.  The tumorigenic liver fluke Opisthorchis viverrini--multiple pathways to cancer.

Authors:  Banchob Sripa; Paul J Brindley; Jason Mulvenna; Thewarach Laha; Michael J Smout; Eimorn Mairiang; Jeffrey M Bethony; Alex Loukas
Journal:  Trends Parasitol       Date:  2012-09-01

9.  A granulin-like growth factor secreted by the carcinogenic liver fluke, Opisthorchis viverrini, promotes proliferation of host cells.

Authors:  Michael J Smout; Thewarach Laha; Jason Mulvenna; Banchob Sripa; Sutas Suttiprapa; Alun Jones; Paul J Brindley; Alex Loukas
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

10.  Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.

Authors:  Kusumawadee Utispan; Peti Thuwajit; Yoshimitsu Abiko; Komgrid Charngkaew; Anucha Paupairoj; Siri Chau-in; Chanitra Thuwajit
Journal:  Mol Cancer       Date:  2010-01-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.